Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 33

1.

Novel short-fragment PCR assay for highly sensitive broad-spectrum detection of anogenital human papillomaviruses.

Kleter B, van Doorn LJ, ter Schegget J, Schrauwen L, van Krimpen K, Burger M, ter Harmsel B, Quint W.

Am J Pathol. 1998 Dec;153(6):1731-9.

2.
3.

DNA-EIA to detect high and low risk HPV genotypes in cervical lesions with E6/E7 primer mediated multiplex PCR.

Clavel C, Rihet S, Masure M, Chypre C, Boulanger JC, Quereux C, Birembaut P.

J Clin Pathol. 1998 Jan;51(1):38-43.

4.

PCR detection of human papillomavirus: comparison between MY09/MY11 and GP5+/GP6+ primer systems.

Qu W, Jiang G, Cruz Y, Chang CJ, Ho GY, Klein RS, Burk RD.

J Clin Microbiol. 1997 Jun;35(6):1304-10.

5.

The use of general primers GP5 and GP6 elongated at their 3' ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR.

de Roda Husman AM, Walboomers JM, van den Brule AJ, Meijer CJ, Snijders PJ.

J Gen Virol. 1995 Apr;76 ( Pt 4):1057-62.

PMID:
9049358
6.

A general primer GP5+/GP6(+)-mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings.

Jacobs MV, Snijders PJ, van den Brule AJ, Helmerhorst TJ, Meijer CJ, Walboomers JM.

J Clin Microbiol. 1997 Mar;35(3):791-5.

7.

Comprehensive study of several general and type-specific primer pairs for detection of human papillomavirus DNA by PCR in paraffin-embedded cervical carcinomas.

Baay MF, Quint WG, Koudstaal J, Hollema H, Duk JM, Burger MP, Stolz E, Herbrink P.

J Clin Microbiol. 1996 Mar;34(3):745-7.

8.

Papillomavirus infections--a major cause of human cancers.

zur Hausen H.

Biochim Biophys Acta. 1996 Oct 9;1288(2):F55-78. Review.

PMID:
8876633
9.

Second-generation line probe assay for hepatitis C virus genotyping.

Stuyver L, Wyseur A, van Arnhem W, Hernandez F, Maertens G.

J Clin Microbiol. 1996 Sep;34(9):2259-66.

10.

Screening. The next century.

Richart RM.

Cancer. 1995 Nov 15;76(10 Suppl):1919-27. Review.

11.

Intermethod variation in detection of human papillomavirus DNA in cervical smears.

Smits HL, Bollen LJ, Tjong-A-Hung SP, Vonk J, Van Der Velden J, Ten Kate FJ, Kaan JA, Mol BW, Ter Schegget J.

J Clin Microbiol. 1995 Oct;33(10):2631-6.

12.

Detection of cutaneous and genital HPV types in clinical samples by PCR using consensus primers.

Tieben LM, ter Schegget J, Minnaar RP, Bouwes Bavinck JN, Berkhout RJ, Vermeer BJ, Jebbink MF, Smits HL.

J Virol Methods. 1993 May;42(2-3):265-79.

PMID:
8390474
13.

Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay.

Stuyver L, Rossau R, Wyseur A, Duhamel M, Vanderborght B, Van Heuverswyn H, Maertens G.

J Gen Virol. 1993 Jun;74 ( Pt 6):1093-102.

PMID:
8389799
14.

Persistence of type-specific human papillomavirus infection among cytologically normal women.

Hildesheim A, Schiffman MH, Gravitt PE, Glass AG, Greer CE, Zhang T, Scott DR, Rush BB, Lawler P, Sherman ME, et al.

J Infect Dis. 1994 Feb;169(2):235-40.

PMID:
8106758
15.

Association of human papillomavirus with nasal neoplasia.

Wu TC, Trujillo JM, Kashima HK, Mounts P.

Lancet. 1993 Feb 27;341(8844):522-4.

PMID:
8094773
16.

Identification and assessment of known and novel human papillomaviruses by polymerase chain reaction amplification, restriction fragment length polymorphisms, nucleotide sequence, and phylogenetic algorithms.

Bernard HU, Chan SY, Manos MM, Ong CK, Villa LL, Delius H, Peyton CL, Bauer HM, Wheeler CM.

J Infect Dis. 1994 Nov;170(5):1077-85. Erratum in: J Infect Dis 1996 Feb;173(2):516.

PMID:
7963696
17.

Human papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of undetermined significance.

Cox JT, Lorincz AT, Schiffman MH, Sherman ME, Cullen A, Kurman RJ.

Am J Obstet Gynecol. 1995 Mar;172(3):946-54.

PMID:
7892889
18.

Predictive value of human papillomavirus type for histological diagnosis of women with cervical cytological abnormalities.

Burger MP, Hollema H, Pieters WJ, Quint WG.

BMJ. 1995 Jan 14;310(6972):94-5. No abstract available.

19.

Human papillomavirus testing in primary cervical screening.

Cuzick J, Szarewski A, Terry G, Ho L, Hanby A, Maddox P, Anderson M, Kocjan G, Steele ST, Guillebaud J.

Lancet. 1995 Jun 17;345(8964):1533-6.

PMID:
7791438
20.

Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group.

Bosch FX, Manos MM, Muñoz N, Sherman M, Jansen AM, Peto J, Schiffman MH, Moreno V, Kurman R, Shah KV.

J Natl Cancer Inst. 1995 Jun 7;87(11):796-802.

PMID:
7791229
Items per page

Supplemental Content

Write to the Help Desk